Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vein watershed analysis locational method versus computed tomography-guided percutaneous localization for detecting non-palpable peripheral pulmonary nodules: a real-world study of non-inferiority.
Huang C, Chen ZH, Peng LS, Zhang JT, Lin JT, Zhang S, Yang J, Jiang BY, Yang XN, Zhong WZ, Nie Q. Huang C, et al. Among authors: jiang by. Interdiscip Cardiovasc Thorac Surg. 2024 Dec 31:ivae225. doi: 10.1093/icvts/ivae225. Online ahead of print. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 39739332 Free article.
Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma.
Lin JX, Yin K, Yan LX, Zheng MM, Li YS, Zhang SL, Zeng KH, Yan HH, Tu HY, Chen ZH, Zhang XC, Zhou Q, Yang JJ, Jiang BY, Zhang QL, Wu YL. Lin JX, et al. Among authors: jiang by. JTO Clin Res Rep. 2024 Jul 6;5(9):100704. doi: 10.1016/j.jtocrr.2024.100704. eCollection 2024 Sep. JTO Clin Res Rep. 2024. PMID: 39282661 Free PMC article.
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC.
Li YS, Lai WP, Yin K, Zheng MM, Tu HY, Guo WB, Li L, Lin SH, Wang Z, Zeng L, Jiang BY, Chen ZH, Zhou Q, Zhang XC, Yang JJ, Zhong WZ, Yang XN, Wang BC, Pan Y, Chen HJ, Xiao FM, Sun H, Sun YL, Bai XY, Ke EE, Lin JX, Liu SM, Li Y, Luo OJ, Wu YL. Li YS, et al. Among authors: jiang by. Cell Rep. 2024 Aug 27;43(8):114613. doi: 10.1016/j.celrep.2024.114613. Epub 2024 Aug 7. Cell Rep. 2024. PMID: 39116206 Free article.
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
Zhang C, Sun YX, Yi DC, Jiang BY, Yan LX, Liu ZD, Peng LS, Zhang WJ, Sun H, Chen ZY, Wang DH, Peng D, Chen SA, Li SQ, Zhang Z, Tan XY, Yang J, Zhao ZY, Zhang WT, Su J, Li YS, Liao RQ, Dong S, Xu CR, Zhou Q, Yang XN, Wu YL, Zhang ZM, Zhong WZ. Zhang C, et al. Among authors: jiang by. Cell Rep Med. 2024 Jul 16;5(7):101615. doi: 10.1016/j.xcrm.2024.101615. Epub 2024 Jun 18. Cell Rep Med. 2024. PMID: 38897205 Free PMC article. Clinical Trial.
103 results